UCF Researchers Develop Multiplex Biosensor for HIV and Hepatitis Detection
Electrochemical biosensor aims to simultaneously detect HIV, Hepatitis B, and Hepatitis C in resource-limited settings using RNA-level identification.
Electrochemical biosensor aims to simultaneously detect HIV, Hepatitis B, and Hepatitis C in resource-limited settings using RNA-level identification.
Teams complete whole human genome sequencing and analysis in under four hours, demonstrating potential for same-day NICU workflows.
The upgrade leverages technology by Ultima Genomics and processing at the Gene by Gene lab.
New TheraPEAK products include mammalian-derived cytokines for immune cell expansion and chemically defined medium for AAV production.
A study of over 10 million men reveals frequent testing of patients unlikely to benefit, raising questions about current screening practices.